KEGG   DRUG: Volociximab
Entry
D06319                      Drug                                   

Name
Volociximab (USAN)
Formula
C6434H9942N1706O2040S52
Exact mass
145409.2142
Mol weight
145499.3695
Efficacy
Aging-related macular degeneration therapeutic agent, Antineoplastic, Angiogenesis inhibitor, Anti-alpha5beta1 integrin antibody
Comment
Monoclonal antibody
Treatment of solid tumors and age-related macular degeneration
Target
ITGA5/ITGB1 [HSA:3678 3688] [KO:K06484 K05719]
  Pathway
hsa04510  Focal adhesion
hsa04512  ECM-receptor interaction
hsa04810  Regulation of actin cytoskeleton
Brite
Target-based classification of drugs [BR:br08310]
 Cell surface molecules and ligands
  Cell adhesion molecules: other families
   Integrins
    ITGA5/ITGB1
     D06319  Volociximab (USAN)
Other DBs
CAS: 558480-40-3
PubChem: 47207976

» Japanese version   » Back

  All links  
Ontology (1)   
   KEGG BRITE (1)   
Chemical substance (1)   
   PubChem (1)   
Gene (4)   
   KEGG ORTHOLOGY (2)   
   KEGG GENES (2)   
All databases (6)   

Download RDF
DBGET integrated database retrieval system